ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$27.36
+0.49 (+1.82%)
Performance
1D
—
1W
—
1M
—
3M
+23.08%
6M
+81.19%
1Y
+162.07%
YTD
+24.76%
Open$27.25
Previous Close$26.87
Day High$27.97
Day Low$27.11
52W High$27.94
52W Low$8.73
Volume—
Avg Volume9.29M
Market Cap19.70B
P/E Ratio—
EPS$-1.17
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.00
Above
SMA 200
$16.34
Above
RSI (14)
76.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+194.0% upside
Current
$27.36
$27.36
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 29.22M | 36.21M | 2.76B |
| Net Income | -172,768,919 | -192,679,091 | -140,854,131 |
| Profit Margin | -592.0% | -562.4% | -5.1% |
| EBITDA | -985,533,375 | -1,160,169,400 | -182,068,335 |
| Free Cash Flow | — | — | -125,369,781 |
| Rev Growth | -19.3% | -19.3% | -1.7% |
| Debt/Equity | — | — | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |